Literature DB >> 25048273

[Risk factors for total hip arthroplasty dislocation and its functional outcomes].

J Sanz-Reig1, A Lizaur-Utrilla2, F Miralles-Muñoz2.   

Abstract

OBJECTIVES: To evaluate risk factors for dislocation after primary total hip arthroplasty (THA), and its functional outcomes.
MATERIAL AND METHODS: A retrospective study was conducted on 22 cases with dislocation and 431 controls without dislocation, all performed with lateral access. The data were collected prospectively with a minimum follow-up of 5 years. Patient related factors, from primary surgery, and position of components on simple radiographs were analyzed. Harris and Merle D'Aubigné hip scores, and short Womac questionnaire were used.
RESULTS: Demographic, patient-related or surgical technique factors were not risk predictors of dislocation. With regard to position of components, an acetabular abduction >50° (p = 0.003) and anteversion lower or higher than 10°- 20° (p = 0.044) were risk factors. Controls and dislocation treated conservatively had similar outcomes, and in both were better than in those treated with surgical revision (p = 0.03). DISCUSSION: Factors relating to the patient and soft tissues status may influence the stability of the arthroplasty, but malposition of the acetabular component seems to be the most important and common risk factor for dislocation.
Copyright © 2014. Published by Elsevier Espana.

Entities:  

Keywords:  Artroplastia total de cadera; Dislocation; Factores de riesgo; Luxación; Risk factors; Total hip arthroplasty

Mesh:

Year:  2014        PMID: 25048273     DOI: 10.1016/j.recot.2014.05.005

Source DB:  PubMed          Journal:  Rev Esp Cir Ortop Traumatol        ISSN: 1888-4415


  1 in total

1.  Migration inhibitory factor in spinal tuberculosis: -173G/C polymorphisms, and transcript and protein levels in a northern province of China.

Authors:  Jun Wang; Bin Sheng; XiaoPeng Li; JianMin Sun; Lin Shi; WenTao Wei; GuoWei Wang; XueJun Cao
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.